Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/1195
Title: A phase 1 study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.
Authors: Bartlett, J.B.
Michael, A.
Clarke, I.A.
Dredge, K.
Nicholson, S.
Kristaleit, H.
Polychronis, A.
Pandha, H.
Muller, G.W.
Stirling, D.I.
Zeldis, J.
Dalgleish, A.G.
First Published: 2004
Citation: British Journal of Cancer, 2004, 90 (5), pp.955-961
DOI Link: 10.1038/sj.bjc.6601579
ISSN: 0007-0920
Links: http://hdl.handle.net/2381/1195
Type: Article
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.